160 related articles for article (PubMed ID: 2624011)
1. [Treatment of fetal hemolytic disease using plasmapheresis].
Schwarzlos G; During R; Müller S; Stark KH; Plesse R
Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
[TBL] [Abstract][Full Text] [Related]
2. [Intrauterine exchange transfusion in Rh immunization].
Bollmann R; Schilling H; Ihle W; Möckel A; Zienert A
Zentralbl Gynakol; 1988; 110(1):54-9. PubMed ID: 3281398
[TBL] [Abstract][Full Text] [Related]
3. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
4. Transfusion support in the management of immune haemolytic disorders.
Plapp FV; Beck ML
Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
[No Abstract] [Full Text] [Related]
5. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy--effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja)?].
Heim MU; Weidemann R; Brehm G; Versmold H; Mempel W
Beitr Infusionsther; 1990; 26():302-6. PubMed ID: 1703859
[TBL] [Abstract][Full Text] [Related]
6. [Rhesus erythroblastosis, monitoring and treatment].
Siebers JW; Rasenack R; Hillemanns HG
Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
[TBL] [Abstract][Full Text] [Related]
7. [Report of experiences in 20 years use of intrauterine fetal transfusion in severe Rh-induced hemolytic disease of newborn].
Schwarzlos G; Stark KH; During R; Hille M; Müller S; Plesse R; Scheunemann P; Wilken H
Zentralbl Gynakol; 1988; 110(1):18-24. PubMed ID: 3354274
[TBL] [Abstract][Full Text] [Related]
8. Severe intrauterine hemolysis due to anti-C(w).
Chu HP; Kanagalingam D; Chan DK
Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic disease of the newborn with rarely occurring blood group antibodies].
Dzierzkowa-Borodej W; Olearczyk J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):366-8. PubMed ID: 4193016
[No Abstract] [Full Text] [Related]
10. Quantitative measurement of anti-D during pregnancy using a low ionic strength autoanalyser system.
Douglas R; Staveley JM
N Z Med J; 1972 Sep; 76(484):184-6. PubMed ID: 4629348
[No Abstract] [Full Text] [Related]
11. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
[No Abstract] [Full Text] [Related]
12. Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women.
Clarke CA; Elson CJ; Bradley J; Donohoe WT; Lehane D; Hughes-Jones NC
Lancet; 1970 Apr; 1(7651):793-8. PubMed ID: 4191432
[No Abstract] [Full Text] [Related]
13. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
14. [Study of the amniotic fluid in a severe case of hemolytic disease of the newborn: trial therapy by intra-uterine exchange transfusion].
Mellone O; Sawaya C
Rev Hosp Clin Fac Med Sao Paulo; 1965 Sep; 20(5):258-63. PubMed ID: 5852756
[No Abstract] [Full Text] [Related]
15. [The fight against hemolytic disease of the newborn-- an example of interdisciplinary cooperation].
Müller S; Roewer J; During R; Hille M; Plath C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):720-4. PubMed ID: 2435640
[TBL] [Abstract][Full Text] [Related]
16. The use of plasmapheresis in pregnancy with antenatal prediction of a serious hemolytic disease due to Rh immunization.
Woytoń J; Partyka T; Gajewska E; Kwoczyńska K; Baranowski H; Narczewska B; Bochenek S; Zukowska B; Róg-Malinowski M; Dzierzkowa-Borodej W
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1139-46. PubMed ID: 107917
[TBL] [Abstract][Full Text] [Related]
17. [Intrauterine transfusion in severe hemolytic disease caused by Rh sensitization].
Lampé L; Kelemen J; Komáromy B; Mihály G
Orv Hetil; 1970 Nov; 111(44):2598+. PubMed ID: 5488133
[No Abstract] [Full Text] [Related]
18. The management of severe erythroblastosis fetalis by fetal transfusion: survival of transfused adult erythrocytes in the fetus.
Pattison N; Roberts A
Obstet Gynecol; 1989 Dec; 74(6):901-4. PubMed ID: 2586955
[TBL] [Abstract][Full Text] [Related]
19. In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis.
Grannum PA; Copel JA; Plaxe SC; Scioscia AL; Hobbins JC
N Engl J Med; 1986 May; 314(22):1431-4. PubMed ID: 3702951
[No Abstract] [Full Text] [Related]
20. [Postnatal primary therapy of Morbus haemolyticus neonatorum in prematurely born infants, following intra-uterine foetal transfusion (author's transl)].
Plesse R; Pelz L; Klausch B
Zentralbl Gynakol; 1980; 102(8):457-62. PubMed ID: 7456904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
